-
ATHA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Athira Pharma (ATHA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 77.86 mm | 77.86 mm | 77.86 mm | 77.86 mm | 77.86 mm | 77.86 mm |
Cash burn (monthly) | 1.66 mm | 2.76 mm | 9.87 mm | 9.53 mm | 7.67 mm | 8.12 mm |
Cash used (since last report) | 7.37 mm | 12.27 mm | 43.91 mm | 42.38 mm | 34.13 mm | 36.12 mm |
Cash remaining | 70.49 mm | 65.59 mm | 33.95 mm | 35.48 mm | 43.73 mm | 41.74 mm |
Runway (months of cash) | 42.5 | 23.8 | 3.4 | 3.7 | 5.7 | 5.1 |
13F holders | Current |
---|---|
Total holders | 60 |
Opened positions | 10 |
Closed positions | 16 |
Increased positions | 14 |
Reduced positions | 16 |
13F shares | Current |
---|---|
Total value | 6.78 bn |
Total shares | 17.13 mm |
Total puts | 68.00 k |
Total calls | 111.80 k |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
Perceptive Advisors | 5.40 mm | $2.41 bn |
Vanguard | 1.61 mm | $719.43 mm |
Simplify Asset Management | 1.49 mm | $665.79 mm |
Propel Bio Management | 1.49 mm | $665.79 mm |
Venrock Healthcare Capital Partners II | 1.00 mm | $0.00 |
Tang Capital Management | 600.00 k | $267.60 mm |
BlackRock | 535.54 k | $238.85 mm |
Pathstone | 492.13 k | $219.49 mm |
Acadian Asset Management | 476.50 k | $211.00 k |
Renaissance Technologies | 452.79 k | $201.94 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | Mark Worthington | Common Stock | Sell | Dispose S | No | No | 0 | 8,510 | 0.00 | 83,735 |
2 Jan 25 | Martin Javier San | Common Stock | Sell | Dispose S | No | No | 0 | 10,826 | 0.00 | 35,841 |
2 Jan 25 | Mark James Litton | Common Stock | Sell | Dispose S | No | No | 0 | 25,107 | 0.00 | 242,591 |
2 Jan 25 | Kevin Church | Common Stock | Sell | Dispose S | No | No | 0.5619 | 8,510 | 4.78 k | 130,761 |
2 Jan 25 | Robert Renninger | Common Stock | Sell | Dispose S | No | No | 0 | 2,881 | 0.00 | 89,724 |
31 Dec 24 | Mark Worthington | Common Stock | Option exercise | Acquire M | No | No | 0 | 36,667 | 0.00 | 92,245 |
31 Dec 24 | Mark Worthington | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 36,667 | 0.00 | 73,333 |
31 Dec 24 | Martin Javier San | Common Stock | Option exercise | Acquire M | No | No | 0 | 46,667 | 0.00 | 46,667 |
31 Dec 24 | Martin Javier San | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 46,667 | 0.00 | 93,333 |
31 Dec 24 | Mark James Litton | Common Stock | Option exercise | Acquire M | No | No | 0 | 108,333 | 0.00 | 267,698 |